221 related articles for article (PubMed ID: 31889095)
1. IL-33/ST2 axis promotes glioblastoma cell invasion by accumulating tenascin-C.
Zhang JF; Tao T; Wang K; Zhang GX; Yan Y; Lin HR; Li Y; Guan MW; Yu JJ; Wang XD
Sci Rep; 2019 Dec; 9(1):20276. PubMed ID: 31889095
[TBL] [Abstract][Full Text] [Related]
2. IL‑33 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB pathway.
Zhang JF; Wang P; Yan YJ; Li Y; Guan MW; Yu JJ; Wang XD
Oncol Rep; 2017 Oct; 38(4):2033-2042. PubMed ID: 28849217
[TBL] [Abstract][Full Text] [Related]
3. The Interleukin-33/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation.
Lin L; Li Y; Liu M; Li Q; Liu Q; Li R
Aging (Albany NY); 2020 Jan; 12(2):1685-1703. PubMed ID: 32003751
[TBL] [Abstract][Full Text] [Related]
4. ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.
Sarkar S; Zemp FJ; Senger D; Robbins SM; Yong VW
Neuro Oncol; 2015 Aug; 17(8):1095-105. PubMed ID: 25646025
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
6. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation.
Zhang X; Chen T; Zhang J; Mao Q; Li S; Xiong W; Qiu Y; Xie Q; Ge J
Cancer Sci; 2012 Feb; 103(2):181-90. PubMed ID: 22093097
[TBL] [Abstract][Full Text] [Related]
7. Tenascin C Promotes Glioma Cell Malignant Behavior and Inhibits Chemosensitivity to Paclitaxel via Activation of the PI3K/AKT Signaling Pathway.
Zhang Q; Xu B; Hu F; Chen X; Liu X; Zhang Q; Zuo Y
J Mol Neurosci; 2021 Aug; 71(8):1636-1647. PubMed ID: 33876384
[TBL] [Abstract][Full Text] [Related]
8. Tenascin-C is a novel RBPJkappa-induced target gene for Notch signaling in gliomas.
Sivasankaran B; Degen M; Ghaffari A; Hegi ME; Hamou MF; Ionescu MC; Zweifel C; Tolnay M; Wasner M; Mergenthaler S; Miserez AR; Kiss R; Lino MM; Merlo A; Chiquet-Ehrismann R; Boulay JL
Cancer Res; 2009 Jan; 69(2):458-65. PubMed ID: 19147558
[TBL] [Abstract][Full Text] [Related]
9. Tenascin C promotes cancer cell plasticity in mesenchymal glioblastoma.
Angel I; Pilo Kerman O; Rousso-Noori L; Friedmann-Morvinski D
Oncogene; 2020 Nov; 39(46):6990-7004. PubMed ID: 33077835
[TBL] [Abstract][Full Text] [Related]
10. Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease.
Qi J; Esfahani DR; Huang T; Ozark P; Bartom E; Hashizume R; Bonner ER; An S; Horbinski CM; James CD; Saratsis AM
Acta Neuropathol Commun; 2019 May; 7(1):75. PubMed ID: 31092287
[TBL] [Abstract][Full Text] [Related]
11. IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE
Li Y; Shi J; Qi S; Zhang J; Peng D; Chen Z; Wang G; Wang Z; Wang L
J Exp Clin Cancer Res; 2018 Aug; 37(1):196. PubMed ID: 30119635
[TBL] [Abstract][Full Text] [Related]
12. Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells.
Sarkar S; Mirzaei R; Zemp FJ; Wei W; Senger DL; Robbins SM; Yong VW
Cancer Res; 2017 Jun; 77(12):3231-3243. PubMed ID: 28416488
[TBL] [Abstract][Full Text] [Related]
13. Silencing of Tenascin-C Inhibited Inflammation and Apoptosis Via PI3K/Akt/NF-κB Signaling Pathway in Subarachnoid Hemorrhage Cell Model.
Tong X; Zhang J; Shen M; Zhang J
J Stroke Cerebrovasc Dis; 2020 Jan; 29(1):104485. PubMed ID: 31706751
[TBL] [Abstract][Full Text] [Related]
14. Tenascin-C induces resistance to apoptosis in pancreatic cancer cell through activation of ERK/NF-κB pathway.
Shi M; He X; Wei W; Wang J; Zhang T; Shen X
Apoptosis; 2015 Jun; 20(6):843-57. PubMed ID: 25690319
[TBL] [Abstract][Full Text] [Related]
15. Intermittent hypoxia confers pro-metastatic gene expression selectively through NF-κB in inflammatory breast cancer cells.
Gutsche K; Randi EB; Blank V; Fink D; Wenger RH; Leo C; Scholz CC
Free Radic Biol Med; 2016 Dec; 101():129-142. PubMed ID: 27717868
[TBL] [Abstract][Full Text] [Related]
16. Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays.
Nie S; Gurrea M; Zhu J; Thakolwiboon S; Heth JA; Muraszko KM; Fan X; Lubman DM
J Proteome Res; 2015 Feb; 14(2):814-22. PubMed ID: 25469866
[TBL] [Abstract][Full Text] [Related]
17. IL-33 Promotes Gastric Cancer Cell Invasion and Migration Via ST2-ERK1/2 Pathway.
Yu XX; Hu Z; Shen X; Dong LY; Zhou WZ; Hu WH
Dig Dis Sci; 2015 May; 60(5):1265-72. PubMed ID: 25655003
[TBL] [Abstract][Full Text] [Related]
18. IL-33 promotes the progression of nonrheumatic aortic valve stenosis via inducing differential phenotypic transition in valvular interstitial cells.
He YB; Guo JH; Wang C; Zhu D; Lu LM
J Cardiol; 2020 Feb; 75(2):124-133. PubMed ID: 31416779
[TBL] [Abstract][Full Text] [Related]
19. Tenascin-cmediated vasculogenic mimicry formation via regulation of MMP2/MMP9 in glioma.
Cai HP; Wang J; Xi SY; Ni XR; Chen YS; Yu YJ; Cen ZW; Yu ZH; Chen FR; Guo CC; Zhang J; Ke C; Wang J; Chen ZP
Cell Death Dis; 2019 Nov; 10(12):879. PubMed ID: 31754182
[TBL] [Abstract][Full Text] [Related]
20. Extracellular Matrix Protein Tenascin C Increases Phagocytosis Mediated by CD47 Loss of Function in Glioblastoma.
Ma D; Liu S; Lal B; Wei S; Wang S; Zhan D; Zhang H; Lee RS; Gao P; Lopez-Bertoni H; Ying M; Li JJ; Laterra J; Wilson MA; Xia S
Cancer Res; 2019 May; 79(10):2697-2708. PubMed ID: 30898840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
